av/cymabay-therapeutics--big.svg

COM:CYMABAY

CymaBay Therapeutics Inc

  • Stock

Last Close

32.47

21/03 20:00

Market Cap

3.73B

Beta: -

Volume Today

8.35M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
182K
-
1.18M
546.98%
995.50K
15.46%
604K
-
604K
0%
average payables
677K
-
1.39M
105.47%
1.55M
11.18%
953.50K
38.34%
1.10M
15.89%
1.64M
48.60%
2.24M
36.30%
1.37M
38.92%
1.48M
8.23%
1.91M
29.23%
2.46M
28.77%
average receivables
147.50K
-
262.50K
77.97%
266.50K
1.52%
93K
65.10%
2.50M
2,588.17%
2.50M
0%
343.50K
86.26%
482K
40.32%
138.50K
71.27%
book value per share
1.32
-
1.15
13.06%
1.49
29.41%
0.17
88.71%
2.43
1,349.42%
2.95
21.13%
2.78
5.70%
2.07
25.49%
1.87
9.68%
0.41
77.99%
0.00
99.33%
capex per share
-0.01
-
-0.00
-
-0.00
56.82%
-0.01
1,082.98%
-0.00
48.65%
-0.00
93.51%
-0.00
301.68%
-0.00
37.67%
-0.00
99.75%
capex to depreciation
-5.72
-
-1.45
-
-0.77
46.73%
-5.04
553.09%
-0.55
89.07%
-0.03
93.97%
-0.13
280.56%
-0.21
64.84%
-0.65
213.48%
capex to operating cash flow
0.00
-
0.00
-
0.00
23.53%
0.01
600.16%
0.00
66.59%
0.00
85.41%
0.00
166.87%
0.00
40.48%
0.01
248.55%
capex to revenue
-0.00
-
-0.01
-
cash per share
2.22
-
2.89
29.99%
2.19
24.00%
0.72
66.98%
2.79
284.26%
3.09
10.97%
2.85
7.83%
2.12
25.44%
2.63
23.60%
1.54
41.22%
0.00
99.76%
days of inventory on hand
days payables outstanding
days sales outstanding
182.50
-
debt to assets
0.14
-
0.12
12.06%
0.22
79.65%
0.45
110.33%
0.06
87.13%
0.01
-
0.01
8.49%
0.25
2,148.77%
0.64
151.40%
0.01
98.09%
debt to equity
0.24
-
0.33
36.14%
0.33
1.74%
2.23
574.99%
0.07
96.79%
0.01
-
0.01
5.92%
0.39
3,075.03%
2.51
548.12%
0.02
99.28%
dividend yield
earnings yield
-0.08
-
-0.27
238.63%
-0.49
80.41%
-0.66
35.25%
-0.09
86.95%
-0.16
85.82%
-0.78
387.98%
-0.12
84.18%
-0.39
213.24%
-0.22
43.98%
-0.00
99.98%
enterprise value
106.62M
-
111.36M
4.44%
33.54M
69.88%
38.87M
15.87%
304.16M
682.58%
405.96M
33.47%
108.67M
73.23%
369.00M
239.57%
165.94M
55.03%
621.16M
274.32%
2.51T
403,715.08%
enterprise value over ebitda
-11.59
-
-3.58
69.16%
-2.30
35.72%
-1.54
33.18%
-11.50
648.93%
-5.66
50.78%
-1.11
80.36%
-6.91
521.72%
-1.91
72.32%
-6.82
256.38%
-24.67K
361,677.07%
ev to operating cash flow
-12.61
-
-5.27
58.16%
-1.44
72.73%
-1.66
15.72%
-15.49
830.91%
-7.39
52.30%
-1.11
84.98%
-8.25
643.38%
-2.39
71.03%
-7.39
209.11%
-34.58K
468,013.94%
ev to sales
30.42
-
80.72K
-
free cash flow per share
-0.60
-
-1.76
192.81%
-1.23
29.92%
-1.00
19.15%
-0.56
43.55%
-0.96
70.35%
-1.47
52.72%
-0.65
55.68%
-0.98
50.63%
-0.96
1.95%
-0.00
99.93%
free cash flow yield
-0.07
-
-0.18
168.09%
-0.73
307.63%
-0.58
21.01%
-0.06
89.39%
-0.12
99.14%
-0.75
513.24%
-0.11
84.86%
-0.29
155.81%
-0.15
47.14%
-0.00
99.98%
graham net net
1.26
-
1.03
17.84%
1.41
36.74%
0.07
95.25%
2.36
3,415.36%
2.81
19.15%
2.57
8.58%
1.97
23.43%
1.65
16.12%
0.34
79.42%
0.00
99.30%
graham number
4.62
-
8.28
79.32%
5.24
36.64%
2.07
60.47%
6.58
217.18%
9.12
38.76%
9.77
7.05%
5.74
41.25%
7.41
29.07%
3.54
52.18%
0.01
99.78%
income quality
0.84
-
0.66
21.22%
1.50
127.04%
0.88
41.70%
0.71
18.64%
0.76
6.29%
0.95
25.77%
0.88
7.89%
0.77
12.05%
0.79
2.82%
0.69
13.22%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-11.43
-
-31.80
178.19%
-28.36
10.80%
-19.14
32.53%
-19.75
3.18%
-215.79
992.86%
-33.91
-
-6.25
81.58%
5.37
185.93%
interest debt per share
0.37
-
0.44
16.62%
0.54
23.83%
0.43
20.07%
0.21
52.42%
0.01
97.17%
0.03
451.82%
0.03
21.07%
0.76
2,911.28%
1.21
58.11%
-0.00
100.01%
inventory turnover
invested capital
0.24
-
0.33
36.14%
0.33
1.74%
2.23
574.99%
0.07
96.79%
0.01
-
0.01
5.92%
0.39
3,075.03%
2.51
548.12%
0.02
99.28%
market cap
126.58M
-
118.44M
6.43%
31.94M
73.03%
40.56M
26.99%
321.12M
691.64%
454.95M
41.68%
131.38M
71.12%
395.45M
200.98%
240.17M
39.27%
550.53M
129.23%
2.51T
455,558.77%
net current asset value
18.34M
-
13.61M
25.80%
27.83M
104.56%
3.11M
88.84%
84.24M
2,612.30%
165.23M
96.14%
183.54M
11.08%
140.47M
23.47%
121.72M
13.35%
32.38M
73.40%
261.37M
707.33%
net debt to ebitda
2.17
-
0.23
89.53%
-0.11
148.29%
0.07
161.09%
0.64
856.21%
0.68
6.56%
0.23
65.98%
0.50
113.15%
0.86
72.73%
-0.78
190.60%
1.98
355.24%
net income per share
-0.72
-
-2.65
269.86%
-0.82
68.98%
-1.14
38.45%
-0.79
30.59%
-1.25
58.96%
-1.53
21.53%
-0.71
53.68%
-1.30
84.45%
-1.35
3.92%
-0.00
99.93%
operating cash flow per share
-0.60
-
-1.75
191.39%
-1.23
29.58%
-1.00
19.29%
-0.56
43.53%
-0.95
68.96%
-1.46
53.70%
-0.65
55.55%
-0.98
50.52%
-0.96
2.00%
-0.00
99.93%
payables turnover
receivables turnover
2
-
research and ddevelopement to revenue
1.89
-
2.60
-
return on tangible assets
-0.31
-
-0.85
174.80%
-0.36
57.68%
-1.38
282.19%
-0.26
80.81%
-0.39
46.96%
-0.50
27.92%
-0.32
36.34%
-0.46
44.64%
-0.84
83.16%
-0.24
71.08%
revenue per share
0.29
-
0.00
-
roe
-0.54
-
-2.30
325.43%
-0.55
76.03%
-6.77
1,126.50%
-0.32
95.21%
-0.43
31.23%
-0.55
28.88%
-0.34
37.84%
-0.70
104.22%
-3.29
372.19%
-0.36
89.04%
roic
-0.45
-
-1.04
133.49%
-1.23
17.81%
-2.12
72.24%
-0.19
90.81%
-0.43
119.81%
-0.56
32.06%
-0.34
39.12%
-0.48
41.21%
-0.82
68.54%
-0.34
58.93%
sales general and administrative to revenue
1.24
-
1.67
-
shareholders equity per share
1.32
-
1.15
13.06%
1.49
29.41%
0.17
88.71%
2.43
1,349.42%
2.95
21.13%
2.78
5.70%
2.07
25.49%
1.87
9.68%
0.41
77.99%
0.00
99.33%
stock based compensation to revenue
0.49
-
0.49
-
tangible asset value
18.60M
-
13.85M
25.52%
28.11M
103.00%
3.94M
86.00%
84.95M
2,057.66%
170.42M
100.62%
186.35M
9.35%
142.71M
23.42%
132.94M
6.85%
36.15M
72.80%
292.26M
708.36%
tangible book value per share
1.32
-
1.15
13.06%
1.49
29.41%
0.17
88.71%
2.43
1,349.42%
2.95
21.13%
2.78
5.70%
2.07
25.49%
1.87
9.68%
0.41
77.99%
0.00
99.33%
working capital
22.75M
-
16.77M
26.29%
36.65M
118.53%
9.22M
74.85%
87.23M
846.45%
167.15M
91.61%
185.29M
10.85%
141.73M
23.51%
172.73M
21.88%
122.63M
29.00%
366.96M
199.24%

All numbers in (except ratios and percentages)